Immunome Inc (IMNM)
$18.21 -0.44% Close Oct 30, 2026 Live
Immunome stock today
Immunome closed at $18.21 on October 30, 2026, down 0.44% on the day. Over the past year it returned +14.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.06 billion.
$15.00$20.00$25.00$30.00
NovJan 2026MarMayJulSep
| Period | IMNM | S&P 500 (SPY) |
|---|---|---|
| 1 month | -15.3% | -0.9% |
| 3 months | -21.1% | +2.1% |
| Year to date | -15.2% | +11.7% |
| 1 year | +14.0% | +12.4% |
| 3 years | +106.9% | +88.5% |
| 5 years | -22.3% | +76.0% |
Key statistics
- Market value
- $2.06B
- 52-week range
- $15.24 to $29.82
- Next report
- Nov 5, 2026 (estimated)
About Immunome
Develops immunotherapies and biologics for cancer and infectious disease treatment.
Sector: Health Care
More on Immunome
- Financials: revenue, earnings and segmentsRevenue -23% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $776.88 today
No forecast, no recommendation. This page describes Immunome Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.